Redeye: Bambuser - Accelerated ARR growth

2022-11-02 07:45:00

Redeye raises its estimates but maintains its fair value range unchanged on the back of the Q3 report, which beat expectations on ARR and EBITDA.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.